Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Questcor to Present at UBS Global Life Sciences Conference

September 20, 2010 By Bio-Medicine.Org

UNION CITY, Calif., Sept. 20 /PRNewswire/ — Questcor
Pharmaceuticals, Inc. (Nasdaq:
QCOR
) announced today that it will present at the UBS Global
Life Sciences Conference on Wednesday, September 22, 2010 at The
Grand Hyatt Hotel in New York. Don M. Bailey, President and Chief
Executive Officer, will discuss the Company’s business strategy and
historical financial performance at 3:30 p.m. Eastern Time.

Attendance at this conference is by invitation only. A live
audio and slides webcast of Questcor’s presentation may be accessed
through the Company’s website at www.questcor.com. An archived
replay of the presentation will be available after the live
presentation, and can also be accessed at www.questcor.com.

About Questcor

Questcor Pharmaceuticals is a biopharmaceutical company whose
products help patients with serious, difficult-to-treat medical
conditions.  Questcor’s primary product is H.P. Acthar®
Gel (repository corticotropin injection). H.P. Acthar Gel
(“Acthar”) is an injectable drug that is approved for the treatment
of certain disorders, including the treatment of exacerbations
associated with multiple sclerosis (“MS”) and to induce a diuresis
or a remission of proteinuria in the nephrotic syndrome without
uremia of the idiopathic type or that is due to lupus
erythamatosus. In addition, Acthar is not indicated for, but is
used in treating patients with infantile spasms (“IS”), a rare form
of refractory childhood epilepsy, and opsoclonus myoclonus
syndrome, a rare autoimmune-related childhood neurological
disorder. For more information, please visit www.questcor.com.

‘/>”/>

SOURCE

Related Articles Read More >

A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
UC Berkeley and UC San Diego researchers develop way to restore speech using BCIs (1)
Researchers use BCIs to restore speech in people with paralysis
An image of Abbott's Infinity deep brain stimulation (DBS) implants and leads.
As Abbott studies DBS for depression, what might be next?
Brain EEG rendering from peterschreiber.media on Adobe Stock
Hidden signatures in EEGs could reduce epilepsy misdiagnoses
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe